Respiratory Distress Syndrome, Adult Clinical Trial
Official title:
Risk Assessment of Ventilator-induced Lung Injury in Patients With Acute Respiratory Distress Syndrome: The Role of Morphological Phenotype in ARDS
Although most of the information focuses on understanding how the ventilator produces lung damage, the pulmonary factors that predispose to ventilator-induced lung injury (VILI) have been less studied. Acute respiratory distress syndrome (ARDS) can adopt different morphological phenotypes, with its own clinical and mechanical characteristics. This morphological phenotypes may favor the development of VILI for same ventilatory strategy
The lung in acute respiratory distress syndrome ARDS) is a heterogeneous viscoelastic system,
in which areas with different time constants coexist, causing tidal volume to be distributed
unevenly within an anatomically and functionally reduced lung. The administration of a
disproportionately high tidal volume for this lung predisposes to the over-distension of the
better ventilated alveoli and to the injury by tidal opening and closing of the alveoli more
unstable. In this sense, using low tidal volume and homogenizing the lung by means of the
prone position have proven beneficial in ARDS.
Tidal volume, driving pressure, inspiratory flow and respiratory rate have been identified as
responsible for mechanical ventilation-induced lung injury (VILI). These factors together
represent the mechanical power, the insulting energy which is repeatedly applied to a
vulnerable lung parenchyma.
Although most of the information focuses on understanding how the ventilator produces lung
damage and/or amplifies the existing one, the pulmonary factors that predispose to VILI have
been less studied. Acute respiratory distress syndrome can adopt different morphological
phenotypes, with its own clinical and mechanical characteristics. Understanding how each
subgroup of ARDS responds to the protective ventilatory strategy could help to personalize
treatment.
Objectives: To compare the risk of VILI in two groups of ARDS with different morphological
phenotypes (focal and non-focal), ventilated with the same protective strategy.
Design: Patients with ARDS were ventilated under the same conditions of both tidal volume
(TV) and plateau pressure (PPlat). Positive End Expiratory Pressure (PEEP) was adjusted to
reach 30 cmH2O of PPlat. A CT was performed in inspiration and expiration. Transpulmonary
pressures (TP) were measured and lung volumes calculated (Volume Analysis Software,Toshiba,
Japan). Stress was defined as TP at the end of inspiration (TPinsp) and strain: tidal
volume/End Expiratory Lung Volume Patients were classified into focal and non-focal according
to the distribution of aeration loss in CT. Mann - Whitney U test was used to compare
variables and Pearson correlation coefficient to compare its correlation. Significant: p
<0.05
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03712215 -
STUDY OF ELECTRICAL STIMULATION IN PULMONARY FUNCTION IN INTENSIVE CARE UNIT
|
N/A | |
Completed |
NCT04582201 -
Evaluate the Safety of agenT-797 in Participants With Moderate to Severe Difficulty Breathing Secondary to SARS-CoV-2
|
Phase 1/Phase 2 | |
Recruiting |
NCT01990456 -
Strategies for Optimal Lung Ventilation in ECMO for ARDS: The SOLVE ARDS Study
|
N/A | |
Completed |
NCT01167621 -
Changes in Refractory Acute Respiratory Distress Syndrome (ARDS) Patients Under High Frequency Oscillation-ventilation
|
N/A | |
Terminated |
NCT00233207 -
IC14 Antibodies to Treat Individuals With Acute Lung Injury
|
Phase 2 | |
Completed |
NCT00029328 -
Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT00004494 -
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
|
Phase 1 | |
Completed |
NCT00000579 -
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
|
Phase 3 | |
Recruiting |
NCT03236272 -
Establishment of a Biomarkers-based Early Warning System of Acute Respiratory Distress Syndrome (ARDS)
|
||
Withdrawn |
NCT04508933 -
Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS Patients
|
||
Completed |
NCT02273687 -
Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in Emergency Department
|
N/A | |
Recruiting |
NCT03424798 -
Measuring Heart and Lung Function in Critical Care
|
N/A | |
Recruiting |
NCT01992237 -
Measuring Energy Expenditure in ECMO (Extracorporeal Membrane Oxygenation) Patients
|
N/A | |
Completed |
NCT00719446 -
Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials
|
N/A | |
Completed |
NCT00236262 -
Effect of Positive Expiratory Pressure on Right Ventricular Function in Patients With Respiratory Distress Syndrome
|
N/A | |
Completed |
NCT00157144 -
Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005
|
N/A | |
Completed |
NCT00300248 -
Long-Term Results in Mechanically Ventilated Individuals With Acute Lung Injury/Acute Respiratory Distress Syndrome
|
N/A | |
Completed |
NCT00141726 -
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
|
Phase 2 | |
Recruiting |
NCT00465374 -
A Validation/Interventional Study on Stress Index in Predicting Mechanical Stress in ARDS Patients
|
Phase 3 | |
Completed |
NCT00094406 -
Carbon Monoxide to Prevent Lung Inflammation
|
Phase 1 |